Insider Trading activities of Rapt Therapeutics, Inc. (RAPT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rapt Therapeutics, Inc. (RAPT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rapt Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rapt Therapeutics, Inc. since 2005. The reporting company's ticker symbol is RAPT. The reporting company's CIK number is 1673772.
The total value of stock buying since 2005 is $20,395,200.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rapt Therapeutics, Inc. (RAPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 1,699,600 $20,395,200 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rapt Therapeutics, Inc. insiders (RAPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-04 Robbins Wendye (Director) Buy 1,600 12.00 19,200
2019-11-04 Column Group Ii Management, Lp (10% Owner) Buy 625,000 12.00 7,500,000
2019-11-04 Wong Brian Russell (President and CEO) Buy 25,000 12.00 300,000
2019-11-04 Guthart Leo Buy 415,000 12.00 4,980,000
2019-11-04 Rieflin William Jl (Director) Buy 8,000 12.00 96,000
2019-11-04 Goeddel David V (Director) Buy 625,000 12.00 7,500,000

Insider trading activities including stock purchases, stock sales, and option exercises of RAPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rapt Therapeutics, Inc. (symbol RAPT, CIK number 1673772) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month